Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
18.16
0.99 (5.77%)
At close: Aug 15, 2025, 3:59 PM
18.32
0.85%
After-hours: Aug 15, 2025, 07:44 PM EDT

Stoke Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-88.98M -104.7M -101.07M -85.81M
Depreciation & Amortization
2.18M 2.47M 1.55M 974K
Stock-Based Compensation
27.47M 25.26M 22.85M 16.45M
Other Working Capital
-31.23M -2.82M 42.9M -2.85M
Other Non-Cash Items
623K 1.94M 1.78M 1.26M
Deferred Income Tax
n/a n/a n/a 172K
Change in Working Capital
-28.14M -6.03M 43.02M 46K
Operating Cash Flow
-86.85M -81.07M -31.87M -66.91M
Capital Expenditures
-203K -1.62M -3.96M -1.2M
Cash Acquisitions
n/a n/a 45.34M 75.23M
Purchase of Investments
-167.27M n/a -201.32M -87.23M
Sales Maturities Of Investments
60M 107.56M 159.4M 12M
Other Investing Acitivies
n/a n/a -45.34M -75.23M
Investing Cash Flow
-107.47M 105.95M -45.88M -76.43M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.25M 926K 1.06M -2K
Financial Cash Flow
131.09M 53.01M 46.41M 1.28M
Net Cash Flow
-63.23M 77.89M -31.34M -142.05M
Free Cash Flow
-87.05M -82.68M -35.83M -68.11M